COmprehensive Remote Ischemic Conditioning in Myocardial Infarction
China200 participantsStarted 2017-08-01
Plain-language summary
The primary objective of the CORIC-MI trial is to evaluate whether comprehensive (per, post plus delayed) remote ischemic conditioning (CORIC) as an adjunctive therapy in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) can improve left ventricular function and remodeling at 30 days assessed by cardiac magnetic resonance imaging (CMR) for a minimum follow-up period of 12 months.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Suspected anterior STEMI: new ST-elevation \> 0.1 millivolt (mV) (≥ 0.2 mV in men or ≥ 0.15 mV in women in leads V2-V3) in \> two contiguous leads in V1-V6; new or presumed new left bundle branch block;
* Symptom onset no more than 12 h before presentation and planned primary PCI;
* Age 18 to 75 years;
* Willingness and capability to provide informed consent.
Exclusion Criteria:
* Previous anterior myocardial infarction;
* Previous coronary artery bypass graft (CABG);
* Myocardial infarction or stroke within the previous 30 days;
* Treatment with thrombolysis within the previous 30 days;
* Cardiogenic shock;
* Thrombolysis in myocardial infarction (TIMI) flow grade 2 or 3 at coronary angiography;
* Coronary anatomy or mechanical complication of STEMI (ventricular septal rupture, free wall rupture, acute severe mitral regurgitation) warranting emergent surgery;
* Inability to obtain TIMI flow grade ≥ 2;
* Conditions precluding use of RIC (paresis of lower limb, known severe peripheral artery disease or evidence of lower limb ischemia, and etc.);
* Life expectancy of less than 12 months due to non-cardiac disease such as known malignancy or other comorbid conditions;
* Contraindications to CMR;
* Treated with therapeutic hypothermia before admission;
* Pregnancy and lactating women;
* Participation in another interventional trial.
What they're measuring
1
left ventricular ejection fraction (LVEF) assessed by CMR
Timeframe: at 30 days after MI
Trial details
NCT IDNCT03233919
SponsorChina National Center for Cardiovascular Diseases